Method of testing anticancer agentsensitivity of tumor cells

Details for Australian Patent Application No. 2002224096 (hide)

Owner Eisai Co., Ltd.

Inventors Kato, Hiroyuki; Kuromitsu, Junro; Kawai, Takatoshi; Owa, Takashi; Yokoi, Akira; Nagasu, Takeshi

Agent Griffith Hack

Pub. Number AU-B-2002224096

PCT Pub. Number WO02/42493

Priority 2000357398 24.11.00 JP

Filing date 26 November 2001

Wipo publication date 3 June 2002

Acceptance publication date 27 July 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

27 July 2006 Application Accepted

  Published as AU-B-2002224096

23 November 2006 Standard Patent Sealed

10 May 2007 Assignment Registered

  Eisai Co., Ltd. The patent has been assigned to Eisai R&D Management Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002224097

2002224095-Closed compressor and freezing and air conditioning devices